By Dr Alys Havard

Conference Papers

Tran DT; Havard A; Preen DB; Einarsdottir K; Kemp-Casey A; Randall D; Jorm LR, 2017, 'Birth Outcomes Associated with the Use of Smoking Cessation Pharmacotherapies in Pregnancy: Findings from the Smoking MUMS (Maternal Use of Medications and Safety) Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 435 - 436, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437104300321&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Raichand S; Pearson SA; Buckley NA; Havard A, 2017, 'Estimating the Average Daily Dose of Teratogenic Medicines Dispensed to Women of Child-Bearing Age', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 417 - 417, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437104300290&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Havard A; Tran DT; Preen DB; Einarsdottir K; Jorm LR, 2017, 'Is the Use of Smoking Cessation Pharmacotherapies During Pregnancy Consistent with Clinical Guidelines? Findings from the Smoking MUMS (Maternal Use of Medications and Safety) Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 506 - 507, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437104300436&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ahmed B; Tran D; Jorm L; Havard A, 2017, 'Prevalence of renin-angiotensin system (RAS) blockers exposure during pregnancy and the clinical indications: A Population-Based Cohort Study in NSW (2005-2012).', Canberra, presented at Perinatal Society of Australia and New Zealand, Canberra, 02 May 2017

Havard A; Lujic S; Tran D; Jorm L, 2017, 'Refining an antidepressant-based indicator to improve the ascertainment of depression from Australian administrative data', in International Journal of Population Data Science, Swansea University, http://dx.doi.org/10.23889/ijpds.v1i1.200

Gibson A; Randall D; Tran D; Byrne M; Lawler A; Havard A; Robinson M; Jorm L, 2017, 'Emergency department attendance after telephone triage', in International Journal of Population Data Science, Swansea University, http://dx.doi.org/10.23889/ijpds.v1i1.81

Tran DT; Havard A; Jorm L, 2016, 'Algorithms for assessing person-based consistency among linked records for the investigation of maternal use of medications and safety', in International Journal for Population Data Science, Swansea University, Swansea, pp. 212, presented at International Population Data Linkage Network Conference, Swansea, 24 August 2016 - 26 August 2016, http://dx.doi.org/10.23889/ijpds.v1i1.212

Tran DT; Jorm L; Havard A; Harris MF; Comino E, 2015, 'Variation in the use of primary care services for diabetes management according to country of birth and geography among older Australians', Melbourne, Australia, presented at 9th Health Services and Policy Research Conference, Melbourne, Australia, 07 December 2015 - 09 December 2015

Conference Abstracts

Tran D; Cohen JM; Donald S; Robijn A; Cesta C; Kuru K; Parkin L; Pearson S; Johan R; Zoega H; Zwar N; Havard A, 2024, 'Does use of smoking cessation pharmacotherapies during pregnancy increase the risk of congenital malformations in infants: Findings from a multi-national study', Edinburgh, Scotland, United Kingdom, presented at Society for Research on Nicotine and Tobacco Annual Meeting, Edinburgh, Scotland, United Kingdom, 20 March 2024 - 23 March 2024

Robijn A; Tran D; Cohen JM; Donald S; Cesta CE; Furu K; Pearson S; Reutfors J; Zoega H; Zwar N; Havard A, 2023, 'Prevalence of smoking cessation pharmacotherapy use during pregnancy: a multi-national population-based study', Sydney, presented at Centre of Research Excellence in Medicines Intelligence Symposium 2023, Sydney, 02 November 2023 - 03 November 2023

Tran D; Cohen JM; Donald S; Robijn A; Cesta CE; Kuru K; Parkin L; Pearson S; Reutfors J; Zoega H; Zwar N; Havard A, 2023, 'The risk of congenital malformations in infants exposed in the first trimester to smoking cessation pharmacotherapies: A multi-national cohort study', Sydney, presented at Centre of Research Excellence in Medicines Intelligence Symposium 2023, Sydney, 02 November 2023 - 03 November 2023

Robijn A; Tran D; Cesta CE; Cohen JM; Donald S; Furu K; Parkin L; Pearson S; Reutfors J; Zoega H; Zwar N; Havard A, 2023, 'Utilisation of smoking cessation pharmacotherapies during pregnancy: a multi-national population-based study', Adelaide, South Australia, presented at APSAD Australasian Professional Society on Alcohol and other Drugs 2023, Adelaide, South Australia, 27 October 2023 - 30 October 2023

Tran D; Cesta CE; Cohen JM; Donald S; Furu K; Kelty E; Parkin L; Pearson S; Reutfors J; Robijn AL; Zoega H; Zwar N; Havard A, 2023, 'The safety of quit smoking medications during pregnancy: the risk of congenital malformations in infants', UNSW Sydney, presented at National Drug and Alcohol Research Centre Symposium 2023, UNSW Sydney, 26 October 2023

Tran D; Cesta CE; Cohen JM; Donald S; Kari F; Kelty E; Parkin L; Pearson S; Johan R; Robijn A; Zoega H; Nicholas Z; Havard A, 2023, 'First trimester exposure to smoking cessation pharmacotherapies and the risk of major congenital malformations: A multi-national cohort study', Halifax, Nova Scotia, Canada, presented at 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Halifax, Nova Scotia, Canada, 23 August 2023

Lin J; Pearson S; Greenfield J; Park KH; Havard A; Brieger D; Day R; Falster M; de Oliveira Costa J, 2023, 'Trends in the use of Cardiometabolic Medicines in Australia (2014-2022): Sodium-glucose Co-transporter 2 Inhibitors and Glucagon-like Peptide-1 Analogues', in Trends in the use of Cardiometabolic Medicines in Australia (2014-2022): Sodium-glucose Co-transporter 2 Inhibitors and Glucagon-like Peptide-1 Analogues, presented at Australian Diabetes Congress 2023

Lin J; Pearson S; Greenfield J; Park KH; Havard A; Brieger D; Day R; Falster M, 2023, 'Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 analogues (GLP-1a) for cardiovascular risk in Australia (2014-2022)', in Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 analogues (GLP-1a) for cardiovascular risk in Australia (2014-2022), presented at 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management 2023

Bruno C; Havard A; Gillies M; Coghill D; Brett J; Guastella A; Pearson S-A; Zoega H, 2022, 'Patterns of ADHD medicine use: A population-based study among Australian children and adults (2013-2020)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 71 - 71, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084400136&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Anderson C; Carcel C; Hsu B; Shajahan S; Miller M; Peters S; Randall D; Havard A; Redfern J; Anderson C; Jorm L; Woodward M, 2022, 'Disparities in the prehospital management of stroke between women and men in New South Wales', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, Vol. 17, pp. 18 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000847720500050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

CHAMBERS GM; CHOI SKY; IRVINE K; VENETIS C; HARRIS K; HAVARD A; NORMAN RJ; LUI K; LEDGER W; JORM LR, 2022, 'ANZARD Data Linkage – Agreement Between Births Recorded by Clinics and in NSW Perinatal Data Collection', in Fertility & Reproduction, World Scientific Pub Co Pte Ltd, Vol. 04, pp. 176 - 176, http://dx.doi.org/10.1142/s2661318222740875

Bruno C; Havard A; Hanly M; Falster K; Nassar N; Edwards B; Guastella A; Pearson S-A; Zoega H, 2021, 'Children's relative age and medicine treatment for attention-deficit/hyperactivity disorder (ADHD) across Australian jurisdictions with different school enrolment policies', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 166 - 167, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300335&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Overs B; Toma C; Havard A; Green M; O'Donnell M; Mitchell P; Schofield P; Fullerton J, 2021, 'Medical morbidity and mortality in Australians with bipolar disorder from linked administrative data', in BIPOLAR DISORDERS, WILEY, Vol. 23, pp. 51 - 52, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000663051300119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Camacho X; Havard A; Zoega H; Wilson M; Gomes T; Vigod S; Pearson S; Henry D, 2020, 'Maternal and Neonatal Outcomes Associated with Psychostimulant Use in Pregnancy', in International Journal of Population Data Science, Swansea University, Vol. 5, http://dx.doi.org/10.23889/ijpds.v5i5.1579

Overs B; Toma C; Havard A; Green MJ; Mitchell PB; Schofield PR; Fullerton JM, 2019, 'Identification and characterisation of bipolar disorder in Australia using administrative health data', in BIPOLAR DISORDERS, WILEY, AUSTRALIA, Sydney, Vol. 21, pp. 69 - 70, presented at 21st Annual ISBD Conference on Global Advances in Bipolar Disorder and Depression, AUSTRALIA, Sydney, 20 March 2019 - 23 March 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461513600148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reutfors J; Zoega H; Cesta C; Bateman BT; Cantarutti A; Cohen J; Corrao G; Einarsdottir K; Engeland A; Furu K; Havard A; Hernandez-Diaz S; Huybrechts KF; Karlsson P; Karlstad O; Li J; Schaffer A; Yu Y; Broms G, 2018, 'Antipsychotic drug use in pregnancy: A multinational database study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 27, pp. 235 - 235

Havard A; Shakeshaft A; Conigrave K, 2009, 'MAILED FEEDBACK FOR AT-RISK DRINKERS PRESENTING TO RURAL EMERGENCY DEPARTMENTS', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, Vol. 28, pp. A28 - A28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reports

Tran DT; Raichand S; Havard A; Jorm L, 2017, Rapid environmental scan and literature review on avoidable hospital readmission indicators

Tran DT; gibson A; randall D; havard A; jorm L, 2015, Mapping the outcomes of calls to the healthdirect helpline

Tran D; Gibson AE; Randall D; Havard A; Jorm L, 2015, Mapping the outcome of calls to the healthdirect helpline (Final Report), Centre for Big Data Research in Health, UNSW Australia

Vogl LE; Newton NC; Teesson M; Swift W; Karageorge A; Deans C; McKetin R; Steadman B; Jones J; Dillon P; Havard AE; Andrews G, 2012, Climate Schools: Universal computer-based programs to prevent alcohol and other drug use in adolescence, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, 321, http://ndarc.med.unsw.edu.au/resource/climate-schools-universal-computer-based-programs-prevent-alcohol-and-other-drug-use

Vogl LE; Newton NC; Teesson M; Swift W; Karageorge A; Havard A; Deans C; McKetin R; Steadman B; Dillon P; Andrews G, 2009, Climate Schools: Drug prevention programs, Prepared for Australian Government Department of Health and Ageing, Sydney

Shanahan M; Havard A; Mills K; Williamson A; Ross J; Teesson M; Darke S; Ali R; Ritter A; Cooke R; Lynskey M, 2003, Health services use and treatment costs over 12 months among heroin users: Findings from the Australian Treatment Outcome Study (ATOS), National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/TR.203.pdf

Ross JE; Lynskey M; Teesson M; Darke S; Havard A; Mills K; Williamson A; Hetherington K; Fairbairn S, 2003, Three Month Outcomes for the Treatment of Heroin Dependence Findings from the Australian Treatment Outcome Study (ATOS), New South Wales, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/TR.159.PDF

Ross J; Lynskey M; Teesson M; Darke S; Havard A; Mills K; Williamson A; Hetherington K; Fairbairn S, 2003, Three month outcomes for the treatment of heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS) New South Wales, NDARC UNSW, Sydney, https://ndarc.med.unsw.edu.au/resource/three-month-outcomes-treatment-heroin-dependence-findings-australian-treatment-outcome

Teesson M; Ross JE; Darke S; Lynskey M; Mills K; Williamson A; Hetherington K; Fairbairn S; Havard A; Wilhelm E; Shanahan M, 2003, Twelve month outcomes of the treatment of heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS) New South Wales, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/TR.191.pdf

Back to profile page